cristy m. thomas fnp-bc university of nevada school of medicine university medical center, las vegas...

20
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Upload: suzanna-thompson

Post on 17-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Cristy M. Thomas FNP-BCUniversity of Nevada School of

MedicineUniversity Medical Center, Las Vegas

NVNevada’s Only Level 1 Adult Trauma,

Level 2 Pediatric Trauma centers

Page 2: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

30-40 percent of trauma deaths are secondary to exsanguination

Causes of Coagulopathy in Trauma Bleeding Fluid Resuscitation Transfusions-PRBC Hypothermia Multiple injuries

Page 3: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Hypothermia Acidosis Progressive Coagulopathy

Page 4: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Multifactoral Dilution Consumption of Platelets Coagulation factor dysfunction of coagulation

system

Page 5: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Partial thromboplastin time (PTT) Intrinsic Pathway

Prothrombin time (PT) Extrinsic Pathway

Thrombin time Common Pathway

Page 6: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Fresh frozen plasmaCryoprecipitateEpsilon-amino-caproic acid (Amicar)DDAVPRecombinant human factor VIIa (Novoseven)

Page 7: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

SourcePlatelet concentrate (Random donor)

Each donor unit should increase platelet count ~10,000 /µlPheresis platelets (Single donor)

StorageUp to 5 days at room temperature

“Platelet trigger”Bone marrow suppressed patient (>10-20,000/µl)Bleeding/surgical patient (>50,000/µl)

Page 8: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Transfusion reactionsHigher incidence than in RBC transfusionsRelated to length of storage/leukocytes/RBC mismatchBacterial contamination

Platelet transfusion refractorinessAlloimmune destruction of platelets (HLA antigens)Non-immune refractoriness

Microangiopathic hemolytic anemiaCoagulopathySplenic sequestrationFever and infectionMedications (Amphotericin, vancomycin, ATG, Interferons)

Page 9: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Content - plasma (decreased factor V and VIII)Indications

Multiple coagulation deficiencies (liver disease, trauma)DICWarfarin reversalCoagulation deficiency (factor XI or VII)

Dose (225 ml/unit)10-15 ml/kg

NoteViral screened productABO compatible

Page 10: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Prepared from FFPContent

Factor VIII, von Willebrand factor, fibrinogen

IndicationsFibrinogen deficiencyUremiavon Willebrand disease

Dose (1 unit = 1 bag)1-2 units/10 kg body weight

Page 11: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

MechanismPrevent activation plaminogen -> plasmin

Dose50mg/kg po or IV q 4 hr

UsesPrimary menorrhagiaOral bleedingBleeding in patients with thrombocytopeniaBlood loss during cardiac surgery

Side effectsGI toxicityThrombi formation

Page 12: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

MechanismIncreased release of VWF from endothelium

Dose0.3µg/kg IV q12 hrs150mg intranasal q12hrs

UsesMost patients with von Willebrand diseaseMild hemophilia A

Side effectsFacial flushing and headacheWater retention and hyponatremia

Page 13: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

MechanismActivates coagulation system through extrinsic pathway

Approved UseFactor VIII inhibitors in hemophiliacs

Dose: (1.2 mg/vial)90 µg/kg q 2 hr “Adjust as clinically indicated”

Cost (70 kg person) @ $1/µg~$5,000/dose or $60,000/day

Page 14: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Surgery or trauma with profuse bleedingConsider in patients with excessive bleeding without apparent surgical source and no response to other componentsDose: 50-100ug/kg for 1-2 dosesRisk of thrombotic complications not well defined

Anticoagulation therapy with bleeding20ug/kg with FFP if life or limb at risk; repeat if needed for bleeding

Page 15: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Journal of Emergency Medicine 2009 April Transfusion of Blood Products in Trauma: An

Update Massive Transfusion should be 1:1 Ratio Restrictive Transfusion Protocols Still in need of Prospective Randomized trials

to standardize protocols

Page 16: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Gonzalez et al. (2007) FFP should be given earlier to trauma patients requiring massive transfusions. Journal of Trauma. Jan 62(1) 112-119. Coagulopathies can be improved with strict

protocols 1:1 PRBC to FFP

Page 17: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Davis et al 2004 ICP monitor placement

157 patients in 3 groups INR 0.8-1.2 INR 1.3-1.6 INR>1.7

No difference in complications between the groups and INR correction with FFP only delayed monitor placement and treatment

Page 18: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Ilyas et al 2008 Earlier correction of INR with Factor VIIa

verses platelet transfusion 4 units vs 7 units of plasma Correction time was significantly

improved 2.4 hours vs 10 hrs

Page 19: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Williams et al 2008 Journal of Trauma Elderly patients classified as 50 and older INR >1.5 had a mortality rate of 22.6 %

vs 8.2% Suggestive of early monitoring and

correction or INR in anticoagulated patients 50 and older

Page 20: Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric

Identify and correct any specific defect of hemostasis

Use non-transfusional drugs whenever possible

RBC transfusion for surgical procedures or large blood loss